In the second in a two-part series, the Pharmacy Guild's Trent Twomey discusses the need for reform of opiate dependence therapy, out-of-pocket costs and expresses concern over the challenge companies face in navigating the PBS-listing process. …
Guild's Trent Twomey on costs and the access challenge
April 8, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
PSDs are not an 'obligation' under trade agreement
April 9, 2021 - - Latest News -
More risk for government this time around in agreement negotiation
April 9, 2021 - - Latest News -
This change will not enhance transparency of decision-making
April 9, 2021 - - Latest News -
Daily updates on COVID-19 vaccine - 9 April 2021
April 9, 2021 - - COVID-19 -
Government scraps October timeline after accepting ATAGI advice
April 9, 2021 - - Latest News -
More come forward to question move on confidentiality protections
April 9, 2021 - - Latest News -
Guild's Trent Twomey on costs and the access challenge
April 8, 2021 - - Latest News